ZENTRALKLINIK BAD BERKA t is something unusual for a non-university hospital to operate its own cyclotron to manufacture radioactive drugs for cancer therapy. Zentralklinik Bad Berka (ZBB) has been doing this from as early as and supplying users throughout Germany. The demand is substantial ­ in a new cyclotron is slated to come on stream. It is not only the production of radiopharmaceuticals that defines the special role played by ZBB. Already from , the hospital had a Center for Molecular Imaging with a positron-emission tomograph (PET). And thanks to its nu- merous specialisations, it also succeeds in attracting more and more new patients to the Thuringian spa location despite strong competition from Jena and Erfurt. People travel from all over Germany and even from abroad to be treated at the molecular radiotherapy centre and at the spinal surgery clinic. The designation of an intermediate care hospital is inter- preted by Zentralklinik in its own way: within the major fields of medical work it forms focus areas of particular strength. In the area of cardiology, arrhythmia and heart failure are particularly important, in neurology it is epilep- sy, in abdominal surgery it is severe liver diseases. The aim is to continue to rank as a medical centre of excellence. I 64
RHÖN-KLINIKUM AG Download Center Language
  • English
  • Deutsch